Horizon Scanning in the New Zealand Health System
Horizon scanning is a process or system which seeks to systematically and proactively identify current, new, and emerging health technologies with the potential to significantly impact patients, other stakeholders and the healthcare system. The horizon scanning process may cover a range of technologies including medicines, medical devices, vaccines, tests, diagnostics, and models of care. It […]
Protected: Bringing Nuvaxovid™ to Market: A Novavax Case Study
There is no excerpt because this is a protected post.
HTA Roadmap For a New Vaccine in Australia
The landscape of vaccines in Australia is marked by stringent guidelines and a competitive marketplace and above all a focus on patient outcomes.
Biointelect partnered with a pharmaceutical company, well-versed in the Australian market but new to the vaccine domain, to develop a roadmap that would not only introduce their new vaccine but also potentially secure it a coveted position on the National Immunisation Program (NIP) with premium pricing.
Navigating European Market Access: A Strategic Blueprint for Novel Vaccines
Introduction The European medical market is the second-largest medical device market following the US, requiring newfound innovation for pharmaceutical companies to reach success. A US Biotech firm, on the cusp of introducing a groundbreaking first-in-class vaccine, sought Biointelect’s expertise to illuminate their path in this intricate and highly saturated market. With Biointelect’s strategic guidance and […]
